NCT04120909View on ClinicalTrials.gov

MARC-2: MARKERS AND RESPONSE TO CRT in Non-LBBB

UnknownOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Cardiac Resynchronization Therapy, Non-LBBB, QRS Area
Interventions
DEVICE

Cardiac resynchronization therapy

Biventricular pacing according to current standards.

Trial Locations (1)

Unknown

RECRUITING

Maastricht UMC+, Maastricht

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Maastricht University Medical Center

OTHER

NCT04120909 - MARC-2: MARKERS AND RESPONSE TO CRT in Non-LBBB | Biotech Hunter | Biotech Hunter